India's reputation as the "Pharmacy of the World" rests on its ability to produce high-quality generic medicines at affordable prices. However, the past few years have exposed serious quality challenges…
India's pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to…
India's Central Drugs Standard Control Organization (CDSCO) is the national regulatory authority responsible for approving, monitoring, and regulating pharmaceutical products in the country. For international buyers seeking high-quality generic medicines…
The long-anticipated US-India bilateral trade deal is moving toward finalization, with major implications for India's generic pharmaceutical industry. US President Donald Trump confirmed at the G7 summit in Évian, France…